BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 28355294)

  • 1. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter.
    Hou GX; Liu P; Yang J; Wen S
    PLoS One; 2017; 12(3):e0174515. PubMed ID: 28355294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.
    Bai Y; Li LD; Li J; Lu X
    J Ovarian Res; 2016 Jun; 9(1):35. PubMed ID: 27315793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mining topoisomerase isoforms in gastric cancer.
    Hou G; Deng J; You X; Chen J; Jiang Y; Qian T; Bi Y; Song B; Xu Y; Yang X
    Gene; 2020 Sep; 754():144859. PubMed ID: 32535049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
    You Q; Guo H; Xu D
    Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of KIF23 and Its Prognostic Role in Non-small Cell Lung Cancer: 
Analysis Based on the Data-mining of Oncomine].
    Ye L; Li H; Zhang F; Lv T; Liu H; Song Y
    Zhongguo Fei Ai Za Zhi; 2017 Dec; 20(12):822-826. PubMed ID: 29277180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer.
    Xiong J; Zhang X; Chen X; Wei Y; Lu DG; Han YW; Xu J; Yu D
    Oncotarget; 2017 Feb; 8(8):13157-13165. PubMed ID: 28061457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
    Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
    Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.
    Behrens C; Solis LM; Lin H; Yuan P; Tang X; Kadara H; Riquelme E; Galindo H; Moran CA; Kalhor N; Swisher SG; Simon GR; Stewart DJ; Lee JJ; Wistuba II
    Clin Cancer Res; 2013 Dec; 19(23):6556-65. PubMed ID: 24097870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
    Yang SL; Ren QG; Wen L; Hu JL
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis.
    Gao Z; Shi R; Yuan K; Wang Y
    Tumour Biol; 2016 Nov; 37(11):14979-14987. PubMed ID: 27655285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients.
    Ma H; Wang L; Zhang T; Shen H; Du J
    Tumour Biol; 2016 Jan; 37(1):1341-7. PubMed ID: 26293896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung.
    Giaccone G; van Ark-Otte J; Scagliotti G; Capranico G; van der Valk P; Rubio G; Dalesio O; Lopez R; Zunino F; Walboomers J
    Biochim Biophys Acta; 1995 Dec; 1264(3):337-46. PubMed ID: 8547322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.
    Okabe N; Ezaki J; Yamaura T; Muto S; Osugi J; Tamura H; Imai J; Ito E; Yanagisawa Y; Honma R; Gotoh M; Watanabe S; Waguri S; Suzuki H
    Int J Oncol; 2015 Mar; 46(3):999-1006. PubMed ID: 25586059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression and prognosis of insulin‑like growth factor‑binding protein family members in non‑small cell lung cancer.
    Wang J; Hu ZG; Li D; Xu JX; Zeng ZG
    Oncol Rep; 2019 Nov; 42(5):1981-1995. PubMed ID: 31545451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and potential mechanism of metabolism-related genes and CRLS1 in non-small cell lung cancer.
    Feng HM; Zhao Y; Zhang JP; Zhang JH; Jiang P; Li B; Wang C
    Oncol Lett; 2018 Feb; 15(2):2661-2668. PubMed ID: 29434989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct prognostic roles of HSPB1 expression in non-small cell lung cancer.
    Huang ZC; Li H; Sun ZQ; Zheng J; Zhao RK; Chen J; Sun SG; Wu CJ
    Neoplasma; 2018; 65(1):161-166. PubMed ID: 29017331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of ASCL2 is an independent prognostic indicator in lung squamous cell carcinoma.
    Hu XG; Chen L; Wang QL; Zhao XL; Tan J; Cui YH; Liu XD; Zhang X; Bian XW
    J Clin Pathol; 2016 Apr; 69(4):313-8. PubMed ID: 26483561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.